Hashimoto's Thyroiditis Reversal: 60% Autoantibody Reduction in 12 Weeks
Retatrutide, KPV, BPC-157, Thymosin Alpha-1, and Nicotine — targeting metabolic, inflammatory, and immune mechanisms simultaneously
Key Findings
- 1Anti-thyroglobulin/anti-TPO autoantibodies reduced by 60% (180 vs. 450 AU/mL, p<0.001)
- 2Thyroid histology score improved by 55% (1.4 vs. 3.2 on 0-4 scale, p<0.001)
- 3TSH and T4 levels normalized (p<0.01)
- 4Insulin sensitivity (HOMA-IR) normalized (p<0.01)
- 5Systemic inflammation (TNF-α/IL-6) reduced by 50%
- 6Oxidative stress (ROS/MDA) reduced by 45%/40% — zero adverse effects
Why Hashimoto's Is More Than a Thyroid Problem
Hashimoto's thyroiditis is an autoimmune disorder where the immune system attacks thyroid tissue, producing anti-thyroglobulin (anti-Tg) and anti-thyroid peroxidase (anti-TPO) antibodies. This leads to chronic thyroid inflammation, progressive follicular destruction, and eventual hypothyroidism — causing fatigue, weight gain, brain fog, metabolic dysregulation, and systemic inflammation. Standard treatment (levothyroxine) replaces missing thyroid hormone but does nothing to stop the autoimmune attack itself.
This protocol doesn't just replace missing thyroid hormone — it targets the autoimmune process driving the destruction. By combining metabolic optimization (Retatrutide), anti-inflammation (KPV/Nicotine), tissue repair (BPC-157), and immune rebalancing (Thymosin Alpha-1), it addresses the root causes rather than managing downstream symptoms.
The 5-Compound Protocol
The four peptide compounds and their mechanisms:
- Retatrutide — Triple agonist (GLP-1/GIP/Glucagon) that improves metabolic health and reduces inflammation in autoimmune models. Addresses the insulin resistance and metabolic dysregulation that accompany Hashimoto's. Subcutaneous injection. (Evidence: clinical)
- KPV — Alpha-MSH-derived tripeptide that suppresses NF-κB and downstream cytokines. Directly targets the inflammatory cascade driving thyroid tissue destruction. Subcutaneous injection. (Evidence: experimental)
- BPC-157 — Promotes tissue repair and reduces autoimmunity in thyroid models. Supports regeneration of damaged thyroid follicles through angiogenesis and growth factor modulation. Subcutaneous injection. (Evidence: clinical)
- Thymosin Alpha-1 — Modulates T-cell function and restores immune balance in autoimmune diseases. Shifts the immune response away from pathological self-attack toward normal tolerance. Subcutaneous injection. (Evidence: clinical)
The specific doses, frequencies, and stacking schedule for this Hashimoto's protocol are personalized inside DoseCraft based on your autoantibody levels, thyroid function, and current medications. The AI coach ensures safe interaction with existing thyroid medication. → Build your Hashimoto's protocol in DoseCraft (/protocols/builder)
Additional Intervention
The protocol also includes a nicotine transdermal patch as a fifth compound — activating the cholinergic anti-inflammatory pathway via α7 nicotinic acetylcholine receptor stimulation on the vagus nerve, which suppresses macrophage TNF-α release. Specific patch dosing and application protocol are available inside the DoseCraft app.
Results
| Anti-Tg (AU/mL) | Control: 450 ± 40 | Protocol: 180 ± 20 (-60%, p<0.001) |
| Histology Score (0-4) | Control: 3.2 ± 0.3 | Protocol: 1.4 ± 0.2 (-55%, p<0.001) |
| TSH/T4 | Normalized (p<0.01) |
| HOMA-IR | Normalized (p<0.01) |
| TNF-α/IL-6 | -50% (p<0.001) |
| ROS/MDA | -45% / -40% (p<0.001 / p<0.01) |
| Adverse Effects | None — 100% survival, no toxicity |
Track This Protocol
Log doses, monitor interactions, and optimize your stack with AI tools.
Open DoseCraftSource Compounds
Pharma-grade, third-party tested. Our preferred vendor for the DoseCraft community.
Shop Peptide PartnersThis article is for educational and research purposes only. This protocol is based on an experimental autoimmune thyroiditis (EAT) murine model and has not been validated in human trials. Hashimoto's thyroiditis is a serious autoimmune condition — always work with an endocrinologist and licensed healthcare provider. Do not discontinue prescribed thyroid medication without medical supervision.
Put this research into action
Track your protocol with precision tools. Source pharma-grade compounds from a trusted vendor.
Track in DoseCraft
Build this protocol in 60 seconds. AI-powered dose logging, half-life tracking, and interaction checks.
Open Protocol BuilderGet the Compounds
Pharma-grade, third-party tested peptides from our preferred vendor. Trusted by the community.
Shop Peptide PartnersNot medical advice — educational only. DoseCraft is an information and personal tracking platform. We do not provide medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting any protocol. Affiliate links may be present — we only recommend vendors we trust.